Literature DB >> 18799718

Sympathetic activation in chronic renal failure.

Markus P Schlaich1, Flora Socratous, Sarah Hennebry, Nina Eikelis, Elisabeth A Lambert, Nora Straznicky, Murray D Esler, Gavin W Lambert.   

Abstract

The potential involvement of sympathetic overactivity has been neglected in this population despite accumulating experimental and clinical evidence suggesting a crucial role of sympathetic activation for both progression of renal failure and the high rate of cardiovascular events in patients with chronic kidney disease. The contribution of sympathetic neural mechanisms to the occurrence of cardiac arrhythmias, the development of hypertension, and the progression of heart failure are well established; however, the exact mechanisms contributing to heightened sympathetic tone in patients with chronic kidney disease are unclear. This review analyses potential mechanisms underlying sympathetic activation in chronic kidney disease, the range of adverse consequences associated with this activation, and potential therapeutic implications resulting from this relationship.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18799718     DOI: 10.1681/ASN.2008040402

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  131 in total

1.  Endovascular radiofrequency renal denervation in treating refractory arterial hypertension: a preliminary experience.

Authors:  G Simonetti; A Spinelli; R Gandini; V Da Ros; E Gaspari; I Coco; M De Francesco; D Santucci; N Di Daniele; R Lauro
Journal:  Radiol Med       Date:  2012-01-07       Impact factor: 3.469

Review 2.  A sympathetic view of human obesity.

Authors:  Elisabeth A Lambert; Nora E Straznicky; Gavin W Lambert
Journal:  Clin Auton Res       Date:  2012-06-21       Impact factor: 4.435

3.  Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Activated intrarenal renin-angiotensin system is correlated with high blood pressure in humans.

Authors:  Hiroyuki Kobori; Qi Fu; Steven D Crowley; Romer A Gonzalez-Villalobos; Ruy R Campos
Journal:  J Appl Physiol (1985)       Date:  2010-12

Review 4.  Novel insights into the physiology of renalase and its role in hypertension and heart disease.

Authors:  Gary Desir
Journal:  Pediatr Nephrol       Date:  2011-03-20       Impact factor: 3.714

5.  Renal denervation in moderate to severe CKD.

Authors:  Dagmara Hering; Felix Mahfoud; Antony S Walton; Henry Krum; Gavin W Lambert; Elisabeth A Lambert; Paul A Sobotka; Michael Böhm; Bodo Cremers; Murray D Esler; Markus P Schlaich
Journal:  J Am Soc Nephrol       Date:  2012-05-17       Impact factor: 10.121

Review 6.  Renal denervation for arrhythmias: hope or hype?

Authors:  Jonathan S Steinberg; Evgeny Pokushalov; Suneet Mittal
Journal:  Curr Cardiol Rep       Date:  2013-09       Impact factor: 2.931

7.  Effect of icodextrin on heart rate variability in diabetic patients on peritoneal dialysis.

Authors:  Oscar Orihuela; María de Jesús Ventura; Marcela Ávila-Díaz; Alejandra Cisneros; Marlén Vicenté-Martínez; María-del-Carmen Furlong; Zuzel García-González; Diana Villanueva; Guadalupe Alcántara; Bengt Lindholm; Elvia García-López; Cleva Villanueva; Ramón Paniagua
Journal:  Perit Dial Int       Date:  2014 Jan-Feb       Impact factor: 1.756

Review 8.  The sympathetic nervous system alterations in human hypertension.

Authors:  Guido Grassi; Allyn Mark; Murray Esler
Journal:  Circ Res       Date:  2015-03-13       Impact factor: 17.367

Review 9.  Integration of renal sensory afferents at the level of the paraventricular nucleus dictating sympathetic outflow.

Authors:  Hong Zheng; Kaushik P Patel
Journal:  Auton Neurosci       Date:  2016-08-06       Impact factor: 3.145

10.  Firing probability and mean firing rates of human muscle vasoconstrictor neurones are elevated during chronic asphyxia.

Authors:  Cynthia Ashley; Danielle Burton; Yrsa B Sverrisdottir; Mikael Sander; David K McKenzie; Vaughan G Macefield
Journal:  J Physiol       Date:  2010-01-05       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.